These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 102108)

  • 1. In vitro sensitivity of Trichomonas vaginalis and Candida albicans to chemotherapeutic agents.
    Lövgren T; Salmela I
    Acta Pathol Microbiol Scand B; 1978 Jun; 86B(3):155-8. PubMed ID: 102108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.
    Debbia EA; Campora U; Massaro S; Boldrini E; Schito GC
    J Chemother; 1996 Apr; 8(2):96-101. PubMed ID: 8708753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.
    Narcisi EM; Secor WE
    Antimicrob Agents Chemother; 1996 May; 40(5):1121-5. PubMed ID: 8723451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of Trichomonas vaginalis to chemotherapeutic agents.
    Paredes FR; Hawkins DF
    J Obstet Gynaecol Br Commonw; 1973 Jan; 80(1):86-8. PubMed ID: 4540495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microbiological evaluation of the effectiveness of gynalgin in the treatment of vaginitis].
    Sikorski R; Hencner Z; Gliński Z; Wawrzkiewicz K; Radomański T; Milart P; Paszkowski T; Skrzypczak W; Sławiński P; Maruszak E
    Wiad Lek; 1992 Apr; 45(7-8):263-9. PubMed ID: 1462586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metronidazole and tinidazole on NTPDase1 and ecto-5'-nucleotidase from intact cells of Trichomonas vaginalis.
    Tasca T; Borges FP; Bonan CD; De Carli GA; Battastini AM; Sarkis JJ
    FEMS Microbiol Lett; 2003 Sep; 226(2):379-84. PubMed ID: 14553936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitrichomonal properties of derivatives of ethers containing amine and halogenarylalkyl groups].
    Białasiewicz D; Kotełko B; Kurnatowska A; Kwaśniewska J
    Wiad Parazytol; 1990; 36(5-6):281-5. PubMed ID: 2131703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the susceptibility of Candida albicans and Trichomonas vaginalis, on some products used as larvicides, trichomonacides and/or bactericides].
    Lacroix R; Reynouard F; Lacroix J; Combescot C
    Ann Pharm Fr; 1988; 46(3):205-9. PubMed ID: 3066257
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of tinidazole on T. vaginalis in vitro].
    Savoia D; Martinetto P; Pugliese A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
    [No Abstract]   [Full Text] [Related]  

  • 18. Metronidazole-resistant Trichomonas vaginalis.
    Forsgren A; Forssman L
    Br J Vener Dis; 1979 Oct; 55(5):351-3. PubMed ID: 315809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of compounds with potential antiparasitic action. VIII. New oxime ethers in the 1-thiochromone system].
    Kadłubowski R; Błaszkowska J; Horwatt E
    Wiad Parazytol; 1990; 36(5-6):269-74. PubMed ID: 2131701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.